Literature DB >> 402207

Hyperplastic alveolar nodules of the rat mammary gland: tumor-producing capability in vivo and in vitro.

D Sinha, T L Dao.   

Abstract

Carcinogen-induced hyperplastic alveolar nodules failed to form tumors after transplantation into isologous female rats; instead they developed ductal or ductal-alveolar outgrowths. Mammary glands from mid-pregnant female rats showed similar outgrowths following transplantation to the isologous hosts. In vitro and in vivo studies failed to demonstrate that subcarcinogenic doses of 7,12-dimethylbenz(a)anthracene can induce mammary tumorigenesis in the hyperplastic alveolar nodules. Our observations suggest that carcinogen-induced hyperplastic alveolar nodules are not 'preneoplastic' lesions in mammary carcinogenesis in the rat.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402207     DOI: 10.1016/s0304-3835(77)80005-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  5 in total

1.  The stability of events in the natural history of neoplasia.

Authors:  H C Pitot
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

2.  Considerations on the preneoplastic lesions of the mammary gland.

Authors:  P M Gullino
Journal:  Am J Pathol       Date:  1977-11       Impact factor: 5.770

Review 3.  Rat models of premalignant breast disease.

Authors:  H J Thompson; M Singh
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

4.  The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats.

Authors:  D M Purnell
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

Review 5.  Adverse outcome pathways for ionizing radiation and breast cancer involve direct and indirect DNA damage, oxidative stress, inflammation, genomic instability, and interaction with hormonal regulation of the breast.

Authors:  Jessica S Helm; Ruthann A Rudel
Journal:  Arch Toxicol       Date:  2020-05-13       Impact factor: 5.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.